“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart

Article: Gene therapy for β-thalassemia and sickle cell disease in Europe and the United States

€3.03

SKU: product-article-44937 Category: General

Description
Reviews (0)

Description

Gene therapy for β-thalassemia and sickle cell disease in Europe and the United States

Reviews

There are no reviews yet.

Be the first to review “Article: Gene therapy for β-thalassemia and sickle cell disease in Europe and the United States”

You must be logged in to post a review.

Top

Article: Gene therapy for β-thalassemia and sickle cell disease in Europe and the United States

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: INTRODUCTION

Article: Highlights in respiratory oncology

Article: Highlights in squamous cell carcinoma of the head and neck